ID Vaccine Portfolio
Porcilis® PCV M Hyo ID is our newest combined ID vaccine, administered intradermally using our IDAL® device.
This ready-to-use vaccine protects your animals against disease caused by Porcine Circovirus Type 2 (PCV2) and Mesomycoplasma hyopneumoniae (M. hyo) induced lung lesions.
Operational efficiency
Porcilis® vaccines together with the IDAL system provide flexible protection against multiple diseases.
Porcilis® PCV M Hyo ID can be mixed with Porcilis® Lawsonia ID in a single vaccine application using the IDAL® 3G device
Porcilis® PCV M Hyo ID can be mixed with Porcilis® Lawsonia ID and used concurrently with Porcilis® PRRS using the IDAL® 3G twin in one vaccination session
*Through the 2nd nozzle
Ready-to-use
vaccines
Easy to combine
for greater efficiency
Highly flexible
licensed vaccination protocols
More convenient
vaccination process
The Broadest Range of Intradermal Vaccines Available
For use on:
Pigs (from 3 weeks of age)
Dose volume:
0.2 ml
Onset of immunity:
PCV2: 2 weeks after vaccination
M. hyo: 4 weeks after vaccination
Duration of immunity:
PCV2: 26 weeks after vaccination
M. hyo: 18 weeks after vaccination
For use on:
Pigs (from 3 weeks of age)
Dose volume:
0.2 ml
Onset of immunity:
4 weeks after vaccination
Duration of immunity:
21 weeks after vaccination
Mixable with Porcilis® PCV ID and with Porcilis® PCV M Hyo ID
For use on:
Pigs (from 3 weeks of age)
Dose volume:
0.2 ml
Onset of immunity:
2 weeks after vaccination
Duration of immunity:
26 weeks after vaccination
Mixable with Porcilis® Lawsonia ID
For use on:
Pigs (from 3 weeks of age)
Dose volume:
0.2 ml
Onset of immunity:
3 weeks after vaccination
Duration of immunity:
22 weeks after vaccination
Always speak to your vet and consult the SPC for more detail.
Prescription decisions are for the person issuing the prescription alone.
Legal category: ROI POM NI POM-V
Porcilis® PCV M Hyo ID Efficacy
Porcilis® PCV M Hyo ID is a ready-to-use, combined vaccine for ID use that protects against PCV2 and M. hyo.
It is proven safe and effective in experimental and field trials
Reduction
in PCV2 viraemia
Reduction
of PCV2 viral load in lungs and lymphoid tissues
Reduction
of faecal virus shedding caused by PCV2 infection
Reduction
of severity of lung lesions caused by M. hyo infection
Reduction
of loss of average daily weight gain due to PCV2 and M. hyo
Mixed and concurrent use
This new vaccine gives added convenience with mixed and concurrent use of up to 4 vaccines in one application.
- Mixed use with Porcilis® Lawsonia ID
- Concurrent use with Porcilis® PRRS using the IDAL® 3G twin device
Animals vaccinated at 3 weeks of age with Porcilis® Lawsonia ID mixed with Porcilis® PCV M Hyo ID and concurrently with Porcilis® PRRS were protected from challenge infection with Lawsonia intracellularis at 4 weeks post vaccination and 18 weeks post vaccination.
This was shown by a statistically significant reduction of:
- Clinical scores
- Weight loss
- Faecal shedding (qPCR faeces)
- Post-mortem ileum lesions scores
Animals vaccinated at 3 weeks of age with Porcilis® PRRS in concurrent use with Porcilis® PCV M Hyo ID, mixed with Porcilis® Lawsonia ID, challenged with Porcilis® PRRS at 4 weeks post vaccination showed:
- Reduced PRRS viraemia
- Reduced loss of ADWG
This combination vaccine is the newest addition to The IDAL® Way portfolio.
Efficiency
IDAL® disperses the vaccine in the skin and the adjacent tissue. This ensures the exposure of antigen to the Langerhans cells, explaining its effectiveness.
Convenience
With IDAL®, it’s easy to control the number of doses applied, either by each vial or the total number per vaccination session.
Welfare
A Needle-Free device deposits the exact vaccine dose through the skin in a fraction of a second, resulting in less stress on pigs.
Swine Protect & Connect™ works together seamlessly, so you have more time and the peace of mind to focus on growing your business and farming operation.
References:
1. Romani N, Flacher V, Tripp CH, Sparber F, Ebner S, Stoitzner P. Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol. 2012;351:113-38.
2. Ferrari L. et al. Evaluation of the immune response induced by intradermal vaccination by using a needle – less system in comparison with the intramuscular route in conventional pigs. Res Vet Sci, 90:64-71. 2011.
● in the 2nd nozzle